Table 4.
Study measures, time and type of assessment
| Questionnaire | Construct | SCREENING (S) |
PRE (T0) |
PRE-POST MODULES |
POST (8 weeks) (T1) |
FU (6 months) (T2) |
|---|---|---|---|---|---|---|
| Socio-demographic data | Demographics | X | – | – | – | – |
| CD-RISC −25 | Resilience (primary outcome) | X | X | – | X | X |
| ODSIS | Overall Depression Severity and Impairment Scale | – | X | X | X | – |
| Suicidal ideation | Risk of suicide | – | X | X | X | – |
| PHQ-9 | Depression severity | X | X | – | X | X |
| BFI-10 | Personality inventory | – | X | – | – | – |
| GAD-7 | Anxiety symptoms | – | X | – | X | X |
| EAHF | Openness to the future scale | – | X | X | X | |
| CSQ | Treatment satisfaction | – | – | – | X | – |
| PANAS | Positive and negative affect | – | X | – | X | X |
| PWBS-29 | Psychological well-being | – | X | – | X | X |
| SCS-SF | Self-compassion | – | X | – | X | X |
| RPA | Response to positive affect | – | X | – | X | X |
| PSS-4 | Perceived stress | – | X | – | X | X |
| OASIS | Overall Anxiety Severity and Impairment Scale | – | X | X | X | – |
| CEQ | Credibility and expectancy of treatment | – | X | – | – | – |
| WAI-TECH | Therapeutic alliance | – | – | – | X | – |